Pulmonary Thromboembolic: Are We Practicing Evidence-Based Medicine?

Friday, November 8th, 2024
8:00 a.m. – 9:00 a.m.
Participate on campus in Mayo 2-002N or via Microsoft Teams.
Recording will be available through the Video Exchange.

Presented by Jeffrey Garland, M.D.
Mayo Clinic
Disclosure Statement: Dr. Jeffrey Garland does not have relevant financial relationships and does not intend to discuss off label / investigational usage of the product.

Learning Objectives
Upon conclusion of this program, participants should be able to:

• Describe the anticoagulant options for the initial, intermediate, and long-term treatment of Pulmonary Embolism
• Analyze the recent Guideline Updates in relation to Pulmonary Embolism
• Differentiate between Massive and Submassive PE, as well as the treatment options for each

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.